It has shown positive initial results for the treatment of Raynaud's disease and dysmenorrhoea, and as a tocolytic, although it is not yet approved for clinical use.
On je pokazao pozitivne inicijalne rezultate u tretmanu Rejnoove bolesti, dismenoreje, i kao tokolitik, mada on još uvek nije odobren za kliničku upotrebu.